Dr.Bornie
@Apichatka
Followers
1K
Following
52K
Statuses
4K
😃 M.D. 😄 Gastroenterology and Hepatology, Prince of Songkla University, Thailand 🌟#liverx 📣https://t.co/7C1acHkfAo
Thailand
Joined June 2014
First day in #APASL2024: mission ✔️ Thank you, Professor Sombat @battan5410 and Professor @WRayKimMD, for the insightful comments🙏🏼 in @AASLDtweets @APASLnews research workshop
3
1
41
RT @NatRevGastroHep: New online! New potent HBV replication inhibitors for the management of chronic hepatitis B are needed
0
9
0
RT @ebtapper: BREAKING: rifaximin and simvastatin did not help people with decompensated cirrhosis Congratulations to @PoseElisa And con…
0
68
0
RT @CACancerJournal: 🌍 Revisit @AmericanCancer @IARCWHO global cancer stats on #WorldCancerDay. ~20 million new cancer cases were diagnosed…
0
14
0
RT @drdemirtass: As today marks #WorldCancerDay, there’s no better time to share with you our latest ILCA Liver Cancer Podcast, where we di…
0
1
0
RT @Gut_BMJ: #GUTAbstract for the paper by Mak et al entitled "Long-term hepatitis B surface antigen response after finite treatment of AR…
0
4
0
RT @ArndtVogel: Tiragolumab in combination with atezolizumab + bevacizumab in advanced or metastatic HCC @TheLancetOncol
0
41
0
RT @GIE_Journal: Editor’s Choice: Florencio de Mesquita et al participate in "EUS-guided coiling plus glue injection compared with endoscop…
0
7
0
RT @BobakMoazzami: New study in @JAMANetworkOpen: Concomitant use of SSRIs with oral anticoagulants (OACs) is linked to a 33% increased ris…
0
2
0
RT @rabataller: MetALD: metabolic syndrome & moderate alcohol 🔸How can we diagnose it ? 🔸Does it impact patient's outcomes? 🔸Why are they…
0
24
0
RT @LancetGastroHep: New research - Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adul…
0
9
0
RT @drtimothyli: Rethinking Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Patients with Cirrhosis ➡️Standard of care sin…
0
41
0
RT @scottisaacsmd: ALD-Met is a new term proposed to describe alcohol-related liver disease for heavy drinkers with metabolic risk factors.…
0
17
0
RT @HepCommJournal: 📑 Atezolizumab/bevacizumab and lenvatinib for #HCC: A comparative analysis in a European real-world cohort https://t.c…
0
9
0
RT @CarlKayMD: Hepatic Hydrothorax & Spontaneous Bacterial Empyema ▪️HH & SBE ➡️ poor prognosis ▪️No MELD exception points for HH/SBE ▪️HH…
0
63
0
RT @HepCommJournal: 📑 Clinical and genetic risk factors for progressive #fibrosis in #MASLD‼️ 💥FIB4 slopes correlated strongly w hepatic o…
0
16
0
RT @RoyAHep: Approaching Complex Difficult HCC phenotypes 🔹Diffuse infiltrative disease 🔹Large Tumours 🔹HCC rupture Comprehensive review…
0
21
0
RT @ArndtVogel: 🔥off the press Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis…
0
48
0
RT @KewinSiah: 🚨 New @AmerGastroAssn update! 🚨 Screening & surveillance are key for #gastric cancer prevention in high-risk U.S. groups. E…
0
17
0
RT @sniezenMD: 🚨 New @AGA_CGH Pub🚨 We developed and validated a ML 🤖model to predict cirrhosis + decompensation in indeterminate fibrosis…
0
12
0